Abstract:Crohn's disease (CD) represents a chronic inflammatory disorder of the intestinal tract. Several susceptibility genes have been linked to CD, though their precise role in the pathogenesis of this disorder remains unclear. Immunity-related GTPase M (IRGM) is an established risk allele in CD. We have shown previously that conventionally raised (CV) mice lacking the IRGM ortholog, Irgm1 exhibit abnormal Paneth cells (PCs) and increased susceptibility to intestinal injury. In the present study, we sought to utilize this model system to determine if environmental conditions impact these phenotypes, as is thought to be the case in human CD. To accomplish this, wild-type and Irgm1-/- mice were rederived into specific pathogen-free (SPF) and germ-free (GF) conditions. We next assessed how these differential housing environments influenced intestinal injury patterns, and epithelial cell morphology and function in wild-type and Irgm1-/- mice. Remarkably, in contrast to CV mice, SPF Irgm1-/- mice showed only a slight increase in susceptibility to dextran sodium sulfate-induced inflammation. SPF Irgm1-/- mice also displayed minimal abnormalities in PC number and morphology, and in antimicrobial peptide expression. Goblet cell numbers and epithelial proliferation were also unaffected by Irgm1 in SPF conditions. No microbial differences were observed between wild-type and Irgm1-/- mice, but gut bacterial communities differed profoundly between CV and SPF mice. Specifically, Helicobacter sequences were significantly increased in CV mice; however, inoculating SPF Irgm1-/- mice with Helicobacter hepaticus was not sufficient to transmit a pro-inflammatory phenotype. In summary, our findings suggest the impact of Irgm1-deficiency on susceptibility to intestinal inflammation and epithelial function is critically dependent on environmental influences. This work establishes the importance of Irgm1-/- mice as a model to elucidate host-environment interactions that regulate mucosal homeostasis and intestinal inflammatory responses. Defining such interactions will be essential for developing novel preventative and therapeutic strategies for human CD.

Genetic and commensal induction of IL-18 drive intestinal epithelial MHCII via IFNγ

Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells

Interleukin-22 induces interleukin-18 expression from epithelial cells during intestinal infection

IEC-intrinsic IL-1R signaling holds dual roles in regulating intestinal homeostasis and inflammation

Epithelial IFNγ signalling and compartmentalized antigen presentation orchestrate gut immunity

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota

Campylobacter infection promotes IFNγ-dependent intestinal pathology via ILC3 to ILC1 conversion

Lineage targeted MHC-II transgenic mice demonstrate the role of dendritic cells in bacterial-driven colitis

Epithelial-specific Blockade of MyD88-dependent Pathway Causes Spontaneous Small Intestinal Inflammation.

Il-22 Deficiency Alters Colonic Microbiota to Be Transmissible and Colitogenic

Modulatory Effects of IFN-γ and IL-22 on Inflammatory Signaling and Cellular Responses in Intestinal Epithelial Cells

IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence

Microbial Colonization Drives Expansion of IL-1 Receptor 1-Expressing and IL-17-Producing Γ/δ T Cells

Select mucosa-associated intestinal commensal bacteria promote gut barrier repair by inducing IL-1b production

Epithelial-myeloid exchange of MHC class II constrains immunity and microbiota composition

Environmental factors regulate Paneth cell phenotype and host susceptibility to intestinal inflammation in Irgm1-deficient mice

Innate lymphoid cells protect host against intestinal pathogen through Id2 dependent IL-22 production and regulation of microbiota. (MUC4P.855)

Transient Activation of Mucosal Effector Immune Responses by Resident Intestinal Bacteria in Normal Hosts is Regulated by Interleukin-10 Signalling

IL-18 maintains the homeostasis of mucosal immune system via inflammasome-independent but microbiota-dependent manner

Bacteroidales recruit IL-6-producing intraepithelial lymphocytes in the colon to promote barrier integrity

IL-22 mediates host defense against an intestinal intracellular parasite in the absence of IFN-γ at the cost of Th17-driven immunopathology